Target intelligence / Profile preview

Methyltransferase like 14 (METTL14)

Target
METTL14
Molecular classification
Enzyme, RNA modification enzyme, Non-catalytic subunit of the N6-methyladenosine (m6A) methyltransferase complex[2][3][7]
01

Overview

Methyltransferase like 14 (METTL14) is a protein encoded by the human METTL14 gene. It functions primarily as a structural component within the N6-methyladenosine (m6A) methyltransferase complex, forming a heterodimer with METTL3. While METTL3 provides catalytic activity for transferring a methyl group from S‑adenosylmethionine to adenosine residues in RNA, METTL14 acts mainly as an RNA-binding scaffold that recognizes substrate RNAs rather than catalyzing reactions itself. The resulting m6A modification regulates various aspects of messenger RNA metabolism including splicing, stability, degradation, and translation efficiency. This process is essential for normal development—such as embryonic stem cell differentiation and neurogenesis—and has been implicated in diseases including several cancers. Aberrant function or expression can contribute to oncogenesis or other pathologies through dysregulation of gene expression at the post-transcriptional level[1][2][5].

Other names
METTL14methyltransferase like 14N6-adenosine-methyltransferase subunithmethyltransferase 14[3]
02

Mechanism of action

Drugs targeting this molecule would likely modulate mRNA methylation by affecting the activity or assembly of the METTL3-METTL14 complex; no approved drugs directly target METTL14 as of now.

03

Biological functions

mRNA bindingmRNA (N6)-methyladenosine methylation (m6A modification)Regulation of mRNA stability and processingRegulation of embryonic stem cell differentiation and neurogenesisRegulation of spermatogenesis and male fertility[2]
04

Disease associations

Cancer (e.g., hepatoblastoma, Wilms tumor, non-small-cell lung cancer)[2][6]
05

Safety considerations

Potential for broad effects on gene expression due to global role in RNA modification; possible impact on cell differentiation and proliferation if targeted therapeutically
06

Biomarkers

Altered expression or mutation status may serve as a biomarker in certain cancers such as hepatoblastoma and Wilms tumor[2]

Beyond the preview

Go deeper on Methyltransferase like 14 (METTL14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methyltransferase like 14 (METTL14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call